Mechanobiology has emerged as a fundamental discipline in understanding tissue regeneration in orthopedic and reconstructive contexts. This review analyzes how mechanical forces—such as tension, compression, shear stress, and controlled loading—regulate biological processes involved in healing across bone, tendon, cartilage, and skin. A structured narrative approach was used to synthesize current evidence from experimental and clinical studies, focusing on mechanotransduction pathways and their clinical implications. The findings demonstrate that tissue regeneration is optimized within a specific mechanical range, where controlled loading enhances cellular activity, extracellular matrix organization, and functional recovery. Conversely, both insufficient mechanical stimulation and excessive loading negatively impact healing outcomes. Additionally, mechanobiological responses are tissue-specific and vary according to the stage of healing, highlighting the importance of progressive and individualized rehabilitation strategies. In reconstructive surgery, mechanical tension plays a critical role in scar formation, where excessive stress is associated with pathological scarring. Overall, this review supports the integration of mechanobiological principles into clinical practice, emphasizing their relevance in improving outcomes in traumatology, orthopedics, and plastic surgery, particularly in diverse healthcare settings.
Immunometabolism has emerged as a key determinant of postoperative outcomes in patients undergoing colorectal surgery, integrating metabolic regulation with immune system function during the perioperative period. Surgical stress induces complex metabolic and inflammatory responses that may become maladaptive in patients with preexisting conditions such as insulin resistance, diabetes mellitus, malnutrition, or sarcopenia. These alterations significantly influence immune competence, tissue repair, and overall recovery. This review analyzes current evidence on the role of immunometabolism in shaping postoperative outcomes, focusing on metabolic status, immune response, nutritional condition, gut microbiota, and perioperative care strategies. The findings highlight that patients with metabolic dysregulation present higher rates of complications, including infections, anastomotic leakage, and prolonged hospital stay. Conversely, interventions such as Enhanced Recovery After Surgery (ERAS) protocols and immunonutrition contribute to improved outcomes by modulating metabolic and inflammatory pathways. Additionally, the gut microbiota is identified as a critical factor influencing immunometabolic balance, particularly in colorectal surgery, where intestinal integrity plays a central role. The integration of these elements supports a multidimensional and personalized approach to surgical care.
Brain connectomics has emerged as a transformative framework in modern neurosurgery, shifting the traditional paradigm from localization-based approaches to network-oriented strategies. This review analyzes the role of structural and functional connectivity mapping in improving surgical planning, enhancing functional preservation, and optimizing postoperative outcomes. Current evidence demonstrates that the integration of techniques such as diffusion tensor imaging, tractography, resting-state functional MRI, and intraoperative mapping allows for a more precise identification of critical brain networks, including white matter tracts and functional hubs. These advances contribute to reducing surgical morbidity and improving the preservation of motor, language, and cognitive functions. Additionally, the use of multimodal approaches provides a comprehensive and individualized understanding of brain organization, supporting the development of safer surgical corridors. Despite these benefits, challenges such as variability in methodologies, limited access to technology, and the need for specialized training remain significant barriers to widespread implementation. From an international perspective, the adoption of connectomic principles is expanding across diverse healthcare systems, highlighting its relevance in both high- and limited-resource settings. Overall, brain connectomics represents a paradigm shift that enhances the precision and safety of neurosurgical interventions, emphasizing the importance of preserving functional networks to improve patient quality of life.
Precision oncology has traditionally focused on genomic profiling to guide targeted therapies; however, increasing evidence suggests that genetic alterations alone are insufficient to fully explain tumor behavior, therapeutic response, and clinical heterogeneity. This review aims to analyze precision oncology beyond genetics by integrating metabolic flexibility, tumor microenvironment dynamics, immune profiling, and systemic physiological factors, with particular emphasis on dermatology and internal medicine in international contexts, including Mexico, Colombia, and Ecuador. A structured narrative review was conducted using the scientific method as a guiding framework, allowing for the systematic identification, analysis, and integration of relevant literature. The findings demonstrate that tumor metabolism, particularly metabolic flexibility, plays a central role in adaptation and resistance. Additionally, the tumor microenvironment and immune profiling are critical determinants of treatment response, especially in the context of immunotherapy. The concept of the kidney as a sensor organ highlights the importance of systemic physiology in oncologic outcomes, particularly regarding drug clearance, toxicity, and metabolic balance. Furthermore, cardiometabolic conditions such as obesity, diabetes, and chronic inflammation significantly influence tumor progression and therapeutic effectiveness. The integration of these dimensions supports a systems-based model of precision oncology, where tumor biology and host factors interact dynamically. This approach is particularly relevant for dermatology and internal medicine, as it allows for a more comprehensive understanding of both local and systemic disease processes. In addition, the proposed framework offers practical applicability in diverse healthcare settings, including regions with limited access to advanced molecular technologies.